Tissue Regenix Group plc Overview
Tissue Regenix Group plc (TSSNF) has a ROE of -8.45%, below the sector sector average of -5.72%.
Get informed when a big investor buys or sells
+ Follow-8.45%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for TSSNF is -8.45%. That is below the sector sector average of -5.72%. Investors often review this figure alongside Tissue Regenix Group plc's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, TSSNF currently prints -8.45% for ROE, while the sector average sits near -5.72%. That is roughly 47.6% below the sector mean. Large gaps often invite a closer look at Tissue Regenix Group plc's growth, margins, and balance sheet.
Return on Equity shows how effectively Tissue Regenix Group plc converts resources into returns. At -8.45%, TSSNF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TSSNF's ROE (-8.45%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
